Want to see NZ:MEE full AI Analyst Report?
Top Page
Me Today Limited
(MEE)
Select Model
Select Model
Rating:46Neutral
Price Target:
$0.09
Action:N/A
Date:10/05/26
The score is primarily constrained by weak financial performance—continued losses and persistent negative free cash flow—despite FY2026 operational improvement and a materially strengthened balance sheet. Technicals are mixed but slightly supportive over the medium/long term, while valuation is limited by negative earnings and no dividend yield data.
Positive Factors
Gross Margin Recovery
The sharp gross-margin recovery indicates meaningful improvement in product economics, pricing, or sales mix. If maintained, stronger gross profit conversion can support operating leverage and reduce the revenue scale required for Me Today to move toward sustainable profitability.
Negative Factors
Persistent Unprofitability
Persistent operating and net losses indicate that the business model has not yet reached sustainable scale. Until profitability improves, Me Today remains dependent on balance-sheet resources or external funding, limiting its ability to reinvest and absorb setbacks.
Read all positive and negative factors
Positive Factors
Negative Factors
Gross Margin Recovery
The sharp gross-margin recovery indicates meaningful improvement in product economics, pricing, or sales mix. If maintained, stronger gross profit conversion can support operating leverage and reduce the revenue scale required for Me Today to move toward sustainable profitability.
Read all positive factors
Me Today Limited (MEE) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$9.67M
Dividend YieldN/A
Average Volume (3M)42.98K
Price to Earnings (P/E)―
Beta (1Y)0.27
Revenue Growth-12.36%
EPS Growth79.80%
CountryNZ
Employees20
SectorGeneral
Sector StrengthN/A
IndustryPackaged Foods
Share Statistics
EPS (TTM)-0.03
Shares Outstanding108,640,190
10 Day Avg. Volume12,610
30 Day Avg. Volume42,979
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)1.51
Price to Sales (P/S)0.58
P/FCF Ratio-2.56
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Me Today Limited Business Overview & Revenue Model
Company Description
Based in Auckland, New Zealand, Me Today Limited, through its various subsidiaries, is dedicated to the creation, distribution, and promotion of health and wellness products. The company offers a comprehensive range of dietary supplements designed...
Me Today Limited Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
34
Negative
Cash Flow
20
Very Negative
| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Mar 2022 | Jun 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 9.80M | 6.53M | 7.45M | 4.33M | 7.88M | 6.62M |
| Gross Profit | 4.91M | 3.31M | 1.51M | 4.33M | 2.03M | 1.65M |
| EBITDA | -1.92M | -1.31M | -4.70M | -4.11M | -4.57M | -4.00M |
| Net Income | -154.00K | -1.48M | -6.02M | -11.28M | -12.97M | -15.64M |
Balance Sheet | ||||||
| Total Assets | 7.33M | 7.33M | 15.20M | 21.46M | 26.95M | 39.46M |
| Cash, Cash Equivalents and Short-Term Investments | 1.83M | 1.83M | 1.26M | 2.84M | 913.00K | 5.37M |
| Total Debt | 2.57M | 2.57M | 15.86M | 15.80M | 13.24M | 13.59M |
| Total Liabilities | 4.82M | 4.82M | 17.54M | 17.86M | 15.02M | 15.36M |
| Stockholders Equity | 2.51M | 2.51M | -2.34M | 3.61M | 11.93M | 24.10M |
Cash Flow | ||||||
| Free Cash Flow | -2.14M | -1.47M | -1.54M | -3.16M | -5.98M | -12.43M |
| Operating Cash Flow | -2.10M | -1.45M | -1.54M | -3.11M | -5.93M | -12.11M |
| Investing Cash Flow | -232.50K | -155.00K | 44.00K | 357.00K | 1.25M | -17.46M |
| Financing Cash Flow | 3.17M | 2.16M | -147.00K | 4.68M | 295.00K | 33.74M |
Me Today Limited Technical Analysis
Neutral
―
Price Trends
0.09
Positive
0.07
Positive
0.06
Positive
Market Momentum
>-0.01
Positive
39.18
Neutral
-16.16
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NZ:MEE, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 0.10, equal to the 50-day MA of 0.09, and equal to the 200-day MA of 0.06, indicating a neutral trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 39.18 is Neutral, neither overbought nor oversold. The STOCH value of -16.16 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for NZ:MEE.
Me Today Limited Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | $45.49M | 16.32 | ― | 3.52% | 17.86% | 20.79% | |
67 Neutral | $98.04M | 7.56 | 9.98% | 1.90% | 10.67% | ― | |
63 Neutral | $37.67M | 0.03 | ― | ― | 29.55% | -11.97% | |
60 Neutral | $33.26M | 54.00 | ― | ― | 16.01% | -28.57% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
46 Neutral | $9.67M | -3.01 | ― | ― | -12.36% | 79.80% | |
44 Neutral | $11.77M | -2.70 | ― | ― | 70.82% | 41.04% |
* General Sector Average
NZ:MEE
Me Today Limited
0.09
0.02
30.88%
NZ:CVT
Comvita
0.76
0.01
1.75%
NZ:BLT
BLIS Technologies Limited
0.03
<0.01
52.94%
NZ:PHL
Promisia Healthcare Limited
0.70
0.26
61.63%
NZ:TAH
Third Age Health Services Limited
4.57
0.11
2.54%
NZ:RUA
Rua Bioscience Ltd.
0.03
-0.01
-31.58%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.